Chemical Test Detects Counterfeit Malaria Drugs
|
By LabMedica International staff writers Posted on 04 Aug 2014 |

Image: The Artesunate Field Test Kit (Photo courtesy of Oregon State University).
A rapid, inexpensive and simple colorimetric-based testing kit for the detection of counterfeit anti-malaria drugs has been developed in order to preserve life and prevent the development of multidrug resistant malaria.
The assay is based on paper microfluidics which offers several advantages over conventional microfluidics, and has great potential to generate inexpensive, easy-to-use, rapid and disposable diagnostic devices and when widely used it could help save hundreds of thousands of lives.
Chemists at the Oregon State University (Corvallis, OR, USA) fabricated a microchip using Whatman filter paper or glass microfiber GF/B (Sigma Aldrich; St. Louis, MO,USA). The filter paper is cut into circular test pads using an 8-mm diameter hole-punch. They designed the paper microchip to enable fluid transport vertically by stacking the paper test pads. Each of the paper cut out has been pretreated by spotting them with different reagents and allowed to dry.
The paper test was divided into layers with the appropriate dried reagents, and the easily prepared sample solution will flow through the regions via capillary action in order to carry out the artesunate detection test. The artesunate sample can then be applied directly onto the test strip/device for measurement. The color will fully develop within minutes so that the user can determine whether artesunate is present in the drug formulation at a therapeutic dose or not. The kit provides a color-coded chart, similar to that accompanying pH paper, which is used to determine the relative concentration of artesunate in the tablet. The paper-based assay, together with the accompanying color chart provides a reliable semi-quantitative measurement of artesunate in a tablet. The rapid, simple, and inexpensive test is especially useful when used as a screening tool for counterfeits in remote areas.
Color measurement of each chip was obtained by using a camera phone application. A sample was applied to the paper chip and allowed to incubate for five minutes for color development. Analysis of the image was performed by measuring the Red, Green, Blue (RGB) value of each spot, and converted to average gray intensity. A single pill can be crushed, dissolved in water, and when a drop of the solution is placed on the paper, it turns yellow if the drug is present. The intensity of the color indicates the level of the drug, which can be compared to a simple color chart.
Vincent T. Remcho, PhD, a professor of chemistry and senior author of the study said, “There are laboratory methods to analyze medications such as this, but they often are not available or widely used in the developing world where malaria kills thousands of people every year. What we need are inexpensive, accurate assays that can detect adulterated pharmaceuticals in the field, simple enough that anyone can use them and our technology should provide that.” The study was published on June 27, 2014, in the journal Talanta.
Related Links:
Oregon State University
Sigma Aldrich
The assay is based on paper microfluidics which offers several advantages over conventional microfluidics, and has great potential to generate inexpensive, easy-to-use, rapid and disposable diagnostic devices and when widely used it could help save hundreds of thousands of lives.
Chemists at the Oregon State University (Corvallis, OR, USA) fabricated a microchip using Whatman filter paper or glass microfiber GF/B (Sigma Aldrich; St. Louis, MO,USA). The filter paper is cut into circular test pads using an 8-mm diameter hole-punch. They designed the paper microchip to enable fluid transport vertically by stacking the paper test pads. Each of the paper cut out has been pretreated by spotting them with different reagents and allowed to dry.
The paper test was divided into layers with the appropriate dried reagents, and the easily prepared sample solution will flow through the regions via capillary action in order to carry out the artesunate detection test. The artesunate sample can then be applied directly onto the test strip/device for measurement. The color will fully develop within minutes so that the user can determine whether artesunate is present in the drug formulation at a therapeutic dose or not. The kit provides a color-coded chart, similar to that accompanying pH paper, which is used to determine the relative concentration of artesunate in the tablet. The paper-based assay, together with the accompanying color chart provides a reliable semi-quantitative measurement of artesunate in a tablet. The rapid, simple, and inexpensive test is especially useful when used as a screening tool for counterfeits in remote areas.
Color measurement of each chip was obtained by using a camera phone application. A sample was applied to the paper chip and allowed to incubate for five minutes for color development. Analysis of the image was performed by measuring the Red, Green, Blue (RGB) value of each spot, and converted to average gray intensity. A single pill can be crushed, dissolved in water, and when a drop of the solution is placed on the paper, it turns yellow if the drug is present. The intensity of the color indicates the level of the drug, which can be compared to a simple color chart.
Vincent T. Remcho, PhD, a professor of chemistry and senior author of the study said, “There are laboratory methods to analyze medications such as this, but they often are not available or widely used in the developing world where malaria kills thousands of people every year. What we need are inexpensive, accurate assays that can detect adulterated pharmaceuticals in the field, simple enough that anyone can use them and our technology should provide that.” The study was published on June 27, 2014, in the journal Talanta.
Related Links:
Oregon State University
Sigma Aldrich
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







